Glucagon-like peptide-1 7-36 amide - Restoragen

Drug Profile

Glucagon-like peptide-1 7-36 amide - Restoragen

Alternative Names: Betatropin; rGLP-1

Latest Information Update: 21 Aug 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Restoragen
  • Class Glucagon-like peptides
  • Mechanism of Action Glucagon-like peptide 1 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Obesity; Type 2 diabetes mellitus
  • Discontinued Cardiovascular disorders

Most Recent Events

  • 21 Aug 2003 No development reported - Phase-II for Obesity in USA (unspecified route)
  • 21 Aug 2003 No development reported - Phase-II for Type-2 diabetes mellitus in USA (unspecified route)
  • 05 Feb 2003 Rights to GLP-1 has been sold from Restoragen to Amylin for the treatment of congestive heart failure in patients ineligible for transplant
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top